Journal Scope
Journal of Stomatology is a scientific quarterly published by the Polish Dental Association. The journal publishes manuscripts covering all dental specialties, related medical disciplines, and affiliated branches of science.
The journal welcomes the following types of submissions: original research articles, clinical research articles, review articles, systematic reviews, short communications, and letters/correspondence. Case reports are not considered for publication. Large case series with literature review are generally not prioritised and may be considered only at the discretion of the Editor.
Letters referring to previously published articles should clearly identify the article discussed, including the title, authors, journal issue, year, and DOI if available. The Editor may also consider commissioned or invited materials, including biographies, commemorative papers, book reviews, and reports from congresses, conferences, symposia, and courses.
The journal does not charge submission or publication fees.
Submission of Manuscripts
All manuscripts must be written in English. Either American or British English may be used, but the style must be consistent throughout the manuscript.
Manuscripts should be submitted through the electronic Editorial System of Journal of Stomatology:
https://www.editorialsystem.com/jos
Tables and figures should be submitted as separate files. Linked files, such as images, graphs, or charts, should also be provided separately.
Title Page
The title page should be submitted as a separate file and must not be included in the anonymized main manuscript file.
The title page must include: full manuscript title; short running title; full names of all authors; institutional affiliations of all authors, including institution, city, and country; ORCID iDs of all authors; corresponding author name, postal address, and e-mail address; word count of the manuscript; number of tables and figures; funding information; conflicts of interest statement; and acknowledgments, if applicable.
The corresponding author is responsible for communication with the journal and for confirming that all authors meet the authorship criteria, approve the submitted version, and agree with the order of authorship.
Preparation of Manuscripts
Article Types and Structure
The structure of the manuscript must correspond to the article type. Manuscripts that do not follow the required structure, ethical requirements, or formatting rules may be returned to authors before external review.
Journal of Stomatology accepts original research articles, clinical research articles, review articles, systematic reviews, short communications, and letters/correspondence. Case reports are not considered for publication. Large case series with literature review may be considered only exceptionally and only at the discretion of the Editor-in-Chief or an assigned editor.
Title
The title should be concise, informative, specific, and accurately reflect the content of the manuscript. Abbreviations should be avoided in the title unless universally recognized. The title should not end with a full stop.
Overly general phrases should be avoided unless necessary for clarity. Where appropriate, the title may include key clinical or scientific information, such as study design, population, intervention, method, or condition.
Original Research Articles
Original research articles should present novel clinical, experimental, epidemiological, or laboratory research with a clearly described methodology and reproducible results. The main text should include Introduction, Objectives, Material and Methods, Results, Discussion, and Conclusions.
The Material and Methods section should include, where applicable, study design, setting, participants or samples, eligibility criteria, procedures, outcome measures, statistical analysis, ethical approval, informed consent, and trial registration.
Clinical Research Articles
Clinical research articles should follow the structure of original research articles and include sufficient information about participants, interventions or clinical procedures, follow-up, outcomes, and ethical safeguards.
Review Articles
Review articles should critically analyse the current state of knowledge. They should include a clear aim, a transparent description of the literature selection approach where applicable, and a balanced discussion of the evidence, limitations, and clinical or scientific implications.
Systematic Reviews and Meta-analyses
Systematic reviews and meta-analyses should follow PRISMA guidance where applicable and should include a completed checklist. Protocol registration is recommended, and the registry name and registration number should be provided when available.
Short Communications
Short communications should present concise original observations, preliminary results, methodological reports, or focused scientific findings of clear relevance to the journal scope.
Letters and Correspondence
Letters to the Editor should present concise comments on articles previously published in the journal, brief scientific observations, or focused correspondence of interest to readers. Letters should not contain an abstract and should cite the article discussed when applicable.
Abstract
An abstract in English must be submitted with the manuscript.
For original research articles, the abstract should be structured and include the following headings:
• Introduction
• Objectives
• Material and Methods
• Results
• Conclusions
The abstract of an original research article should contain 200–300 words.
For review articles, the abstract may be unstructured and should contain 150–250 words.
All abbreviations should be defined at first use in the abstract and again at first use in the main text.
The abstract must accurately reflect the content of the manuscript and must not include data, interpretations, or conclusions that are not presented in the main text.
References, tables, figures, and figure citations should not be included in the abstract. Abbreviations should be kept to a minimum; standard units and universally accepted terms may be used when necessary.
Keywords
The abstract should be followed by 3–5 keywords in English. Authors are encouraged to use terms recommended in Medical Subject Headings — MeSH:
Keywords should reflect the main topics of the manuscript and should not merely repeat words already used in the title.
Main Text
Manuscripts should be submitted in one of the following formats: doc, docx, or rtf.
The main manuscript file should be prepared for double-blind review and should not contain author names, affiliations, acknowledgments, funding information that identifies the authors, or other author-identifying details. Such information should be provided on the title page or in the submission system.
Original research articles should include the following sections:
• Introduction
• Objectives
• Material and Methods
• Results
• Discussion
• Conclusions
Limitations should preferably be discussed within the Discussion section rather than presented as a separate section.
Authors should use generic names of drugs and materials where possible. Laboratory values should be expressed using the International System of Units (SI).
The conclusions should directly correspond to the study objectives and should not merely repeat the results. Conclusions should not be presented as bullet points.
In review articles, systematic reviews and meta-analyses are preferred. Authors of systematic reviews and meta-analyses should follow PRISMA guidance and provide a completed checklist when applicable.
Short Title
Authors should provide a short running title not exceeding 45 characters, including spaces.
References
References should follow the Index Medicus/NLM style:
https://www.nlm.nih.gov/bsd/uniform_requirements.html
References should be numbered in the order in which they appear in the text. The reference list should follow the same numerical order.
References should not exceed:
• 50 references for original articles
• 50 references for narrative review articles
• 20 references for case series
There is no fixed reference limit for systematic reviews and meta-analyses.
Each reference should include:
• surnames and initials of authors;
• full title of the article;
• abbreviated journal title according to Index Medicus;
• year of publication;
• volume number;
• page range;
• DOI, where available.
If there are six or fewer authors, all authors should be listed. If there are seven or more authors, list the first six followed by “et al.”
Example:
Jurczyszyn K, Kubasiewicz-Ross P, Nawrot-Hadzik I, Gedrange T, Dominiak M, Hadzik J. Fractal dimension analysis as a supplementary mathematical method for bone defect regeneration measurement. Ann Anat 2018; 219: 83-88.
For online-only sources, the DOI should be provided. If no DOI is available, the URL and access date should be included.
In-text references should be cited using Arabic numerals in square brackets in the order of first citation in the text. The same reference number should be used for all subsequent citations of the same source.
Reference numbers should be placed consistently, preferably at the end of the relevant sentence or clause. When citing multiple references, use an en dash for consecutive numbers, for example [1-3], and commas for non-consecutive numbers, for example [1,3,5].
References should be limited to the most relevant and up-to-date literature. Excessive self-citation and citation of sources unrelated to the manuscript should be avoided. Authors are responsible for verifying the accuracy and completeness of all references before submission.
References may be cited in table titles, table notes, and figure captions when necessary. Citations should not be embedded inside images.
Tables
Tables should be submitted as separate files in one of the following formats: xls, xlsx, doc, or docx.
Tables should be numbered using Arabic numerals according to the order in which they are cited in the manuscript. Each table should have a clear title and explanatory notes, where necessary.
Figures
Figures should be submitted as separate files. Accepted formats include tiff, cdr, eps, jpg, and png. The minimum resolution is 300 dpi.
Figures should be numbered using Arabic numerals according to the order in which they are cited in the manuscript. Each figure should include a clear caption. If a figure has been previously published or adapted from another source, authors must obtain permission where required and acknowledge the source.
Tables must be submitted in an editable format and should not be provided as images. Graphs are treated as figures.
Patient identity must not be identifiable in figures, photographs, radiographs, or supplementary files. If any material could identify a patient or participant, written informed consent for publication must be obtained and declared in the manuscript.
Supplementary material may be submitted when it supports the manuscript without interrupting the flow of the main text. Supplementary files should be clearly named and cited in the manuscript.
Authorship
Original research articles should generally have no more than 12 authors unless justified by the type of study, for example multicentre research.
Authorship should be limited to individuals who made a substantial intellectual contribution to the work. Each author should meet the following criteria:
• substantial contribution to the conception or design of the study, acquisition of data, analysis, or interpretation of data;
• drafting the manuscript or revising it critically for important intellectual content;
• approval of the final version to be published;
• agreement to be accountable for the integrity and accuracy of the work.
Guest authorship, honorary authorship, and ghost authorship are not acceptable.
Any contributor who does not meet the criteria for authorship should be listed in the Acknowledgments section, with their permission.
Author Contributions
All manuscripts with more than one author must include an Author Contributions statement. This statement will be published in the final article.
Recommended format:
Author Contributions: Conceptualization: [Initials]; Methodology: [Initials]; Investigation and data collection: [Initials]; Formal analysis: [Initials]; Data curation: [Initials]; Writing – original draft: [Initials]; Writing – review and editing: [Initials]; Supervision: [Initials]; Project administration: [Initials]; Funding acquisition: [Initials]. All authors have read and approved the final version of the manuscript.
ORCID
All authors are required to provide an ORCID number. ORCID is a unique digital identifier that supports correct author identification in scientific communication.
Authors can register for an ORCID number free of charge at:
Peer Review Process
Each manuscript is first assessed by the Editorial Office for completeness, scope, ethical compliance, and adherence to journal requirements.
Manuscripts that pass the initial editorial assessment are reviewed by at least two independent reviewers. The journal applies a double-blind peer review process. The identities of reviewers and authors are not disclosed to each other during the review process.
The final editorial decision is made based on the reviewers’ comments, scientific quality, ethical compliance, relevance to the journal scope, and adherence to the instructions for authors.
The peer review process is independent of advertising, sponsorship, institutional interests, and other commercial or personal influences. The journal aims to ensure that peer review is fair, objective, confidential, and free from inappropriate influence.
Submissions by the Editor-in-Chief, Associate Editors, Section Editors, Guest Editors, Editorial Board members, or by authors with a close professional, institutional, personal, or financial relationship with a member of the editorial team are handled under a strict conflict-of-interest procedure.
In such cases, the conflicted editor is excluded from all stages of the editorial and peer review process, including initial assessment, reviewer selection, access to reviewer reports, editorial discussion, and the final decision. The manuscript is assigned to an independent handling editor who has no conflict of interest with the authors, their institutions, or the subject of the manuscript.
If the Editor-in-Chief is an author or co-author of a submitted manuscript, the editorial process is managed by an independent Associate Editor, Section Editor, Guest Editor, or external editor appointed by the publisher or editorial office. The Editor-in-Chief does not participate in reviewer selection, editorial assessment, correspondence concerning the review, or the final decision.
Manuscripts authored by editors or Editorial Board members are subject to the same editorial standards, plagiarism screening, ethical checks, and external peer review as all other submissions. The final decision is made independently by the assigned handling editor.
Duties and Responsibilities of Reviewers
Reviewers are expected to evaluate manuscripts objectively, constructively, and in a timely manner. Reviewers should provide comments that help the Editor make a decision and help authors improve the manuscript.
Reviewers must treat manuscripts, supplementary files, data, figures, and editorial correspondence as confidential. They must not share the manuscript, use unpublished information for personal advantage, or contact authors directly during the review process.
Reviewers should decline an invitation or inform the Editorial Office if they have a conflict of interest, lack relevant expertise, cannot provide an unbiased review, or cannot complete the review within the requested time.
Reviewers should alert the Editorial Office to suspected plagiarism, duplicate publication, ethical concerns, data manipulation, image manipulation, or substantial overlap with published or submitted work.
Duties and Responsibilities of Editors
Editors are responsible for maintaining the quality, integrity, and independence of editorial decisions. Decisions should be based on scientific merit, ethical compliance, relevance to the journal scope, methodological quality, and reviewers' comments, and should not be influenced by commercial, institutional, personal, or political considerations.
Editors must treat submitted manuscripts, reviewer reports, and editorial correspondence as confidential. Editors should manage any conflicts of interest and must not handle manuscripts where relationships or competing interests could affect impartiality.
The Editor-in-Chief or delegated editors may reject manuscripts without external review when they are outside the journal scope, incomplete, ethically non-compliant, scientifically insufficient, or not prepared according to the instructions for authors.
Complaints, appeals, suspected misconduct, and post-publication concerns should be considered in accordance with COPE guidance and handled transparently and fairly.
Editors must recuse themselves from handling manuscripts when a real or perceived conflict of interest could affect impartiality. In such cases, the manuscript is assigned to another qualified editor or to an external editor.
Required Statements
The required statements below are author-facing submission requirements. The complete ethical policies, including publication misconduct, plagiarism, advertising, corrections, expressions of concern, retractions, complaints, appeals, and data sharing, are provided in the separate Ethical Standards and Procedures document on the journal website.
The following statements must be included at the end of the manuscript, before the reference list, where applicable:
• Author Contributions
• Funding
• Institutional Review Board Statement
• Informed Consent Statement
• Clinical Trial Registration
• Data Availability Statement
• Acknowledgments
• Conflicts of Interest
• AI Use Statement
Funding
Authors must disclose all sources of financial, institutional, or material support.
If the study was not funded, please state:
Funding: This research received no external funding.
If funding was received, authors should provide the official name of the funder and the grant number.
If the study was funded, authors should also state whether the funder had any role in study design, data collection, data analysis, interpretation of results, manuscript preparation, or the decision to submit the article.
Institutional Review Board Statement
For studies involving human participants, human data, human tissues, human biological material, animals, or animal-derived material, authors must provide the full name of the ethics committee or institutional review board, approval number, and date of approval.
For studies involving human participants, the following format is recommended:
Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee/Institutional Review Board of [Name of Institution] (approval number: [XXX], date of approval: [date]).
For studies involving animals, authors must confirm that the study was approved by the appropriate ethics committee and conducted in accordance with applicable institutional, national, and international regulations.
If ethical approval was not required, authors must provide a clear explanation and, where possible, a formal exemption or waiver from the appropriate ethics committee.
Recommended format:
Institutional Review Board Statement: Ethical review and approval were waived for this study because [reason].
The Editorial Office may request documentation confirming ethics approval, exemption, or informed consent.
Research on Human Participants and Vulnerable Populations
Research involving human participants, human data, biological material, identifiable images, or medical records must comply with the Declaration of Helsinki and applicable legal, institutional, and ethical requirements.
Studies involving vulnerable populations, including children, persons unable to provide independent informed consent, persons with impaired decision-making capacity, dependent patients, students, employees, prisoners, or other groups at risk of coercion or undue influence, require appropriate ethics committee review and additional safeguards.
Where participants cannot give consent independently, consent must be obtained from a legally authorised representative, parent, or guardian, and assent should be obtained from the participant whenever appropriate.
Authors must describe how risks were minimised, how privacy and confidentiality were protected, and how voluntary participation was ensured.
Informed Consent Statement
For studies involving human participants, human data, or human tissues, authors must include an informed consent statement.
Recommended format:
Informed Consent Statement: Informed consent was obtained from all participants involved in the study.
If informed consent was waived, the reason must be clearly explained.
If the manuscript contains identifiable patient information, clinical images, photographs, videos, radiographs, or case details, written informed consent for publication must be confirmed.
Recommended format:
Informed Consent Statement: Written informed consent for publication was obtained from the patient/participant.
For anonymous surveys and questionnaire studies, authors should state how participants were informed about the aim of the study, voluntary participation, anonymity or confidentiality, data use, and any possible risks.
Clinical Trial Registration
Journal of Stomatology requires prospective registration of clinical trials in a publicly accessible clinical trial registry, in accordance with ICMJE recommendations.
A clinical trial is any study in which participants are prospectively assigned to an intervention, treatment, procedure, diagnostic method, preventive measure, or comparison group to evaluate the effect on a health-related outcome.
Clinical trials must be registered before or at the time of enrolment of the first participant. Ethics committee approval alone is not equivalent to clinical trial registration.
The name of the registry, registration number, and registration date must be provided in the Abstract and in the Materials and Methods section.
Recommended format:
Clinical Trial Registration: This clinical trial was registered in [Registry Name] under registration number [XXX], registration date: [date].
Accepted registries include, but are not limited to:
ClinicalTrials.gov: https://clinicaltrials.gov/
ClinicalTrials.gov Protocol Registration and Results System: https://register.clinicaltrials.gov/
WHO International Clinical Trials Registry Platform: https://trialsearch.who.int/
WHO ICTRP Primary Registries: https://www.who.int/tools/clinical-trials-registry-platform/network/primary-registries
ISRCTN Registry: https://www.isrctn.com/
EU Clinical Trials Information System: https://euclinicaltrials.eu/
EU Clinical Trials Register: https://www.clinicaltrialsregister.eu/
Observational studies, including cohort, case-control, and cross-sectional studies, usually do not require clinical trial registration unless participants are prospectively assigned to a health-related intervention.
If a clinical trial was not prospectively registered, authors must explain the reason in the Materials and Methods section. The Editorial Office may reject clinical trial manuscripts that do not meet registration requirements.
Reporting Guidelines
Authors should follow the appropriate reporting guideline for the study design. Where applicable, a completed checklist should be submitted with the manuscript.
Recommended guidelines include:
CONSORT for randomized clinical trials: https://www.consort-spirit.org/
STROBE for observational studies: https://www.strobe-statement.org/
PRISMA for systematic reviews and meta-analyses: https://www.prisma-statement.org/
ARRIVE for animal studies: https://arriveguidelines.org/
EQUATOR Network for other reporting guidelines: https://www.equator-network.org/
For systematic reviews and scoping reviews, protocol registration is recommended. Authors should provide the registry name and registration number, if available.
Recommended registries for review protocols include:
PROSPERO: https://www.crd.york.ac.uk/prospero/
Open Science Framework Registries: https://osf.io/registries
INPLASY: https://inplasy.com/
protocols.io: https://www.protocols.io/
Data Availability Statement
All manuscripts must include a statement describing whether and how the data supporting the findings are available.
Recommended examples:
Data Availability Statement: The data supporting the findings of this study are available from the corresponding author upon reasonable request.
Data Availability Statement: The data are not publicly available due to ethical, legal, or privacy restrictions.
Data Availability Statement: No new data were created or analyzed in this study.
If data are deposited in a public repository, authors should provide the repository name, DOI, accession number, or direct link.
Acknowledgments
Acknowledgments should be placed at the end of the article, before the reference list.
This section should include individuals or institutions that provided technical, administrative, language, statistical, or material support but do not meet authorship criteria.
Conflicts of Interest
Authors must disclose any financial, institutional, personal, or professional relationships that could be perceived as influencing the study.
If there are no conflicts, please state:
Conflicts of Interest: The authors declare no conflicts of interest.
If the study was funded, authors must also state whether the funder had any role in study design, data collection, data analysis, interpretation of results, manuscript preparation, or the decision to submit the article.
Advertising Policy
Editorial decisions are independent of advertising, sponsorship, commercial partnerships, or other financial interests.
Advertisements or sponsored materials, if present in any journal-related medium, must be clearly identified as advertising or sponsored content and must be kept separate from editorial content.
Acceptance of advertising does not constitute endorsement by the journal, publisher, Polish Dental Association, editors, or editorial board of any product, service, company, or claim.
Editors and reviewers must not be influenced by advertising relationships when selecting manuscripts, selecting reviewers, or making editorial decisions.
Use of Artificial Intelligence Tools
Artificial intelligence tools and large language models cannot be listed as authors.
Authors must disclose the use of artificial intelligence tools if they were used in manuscript preparation, translation, language editing, image generation, data processing, statistical analysis, study design, or interpretation of results.
Recommended format:
AI Use Statement: During the preparation of this manuscript, the authors used [tool name/version] for [purpose]. The authors reviewed and edited the output and take full responsibility for the final content of the manuscript.
If no such tools were used, authors may state:
AI tools must not be listed as authors. Authors remain fully responsible for the accuracy, originality, integrity, validity, and appropriate attribution of all manuscript content, including any text, images, data analysis, or other material prepared with the assistance of AI tools.
AI Use Statement: No artificial intelligence tools were used in the preparation of this manuscript.
Publication Ethics and Scientific Misconduct
Journal of Stomatology follows the principles of publication ethics recommended by the Committee on Publication Ethics (COPE):
https://publicationethics.org/
The journal does not accept plagiarism, data fabrication, data falsification, inappropriate image manipulation, duplicate submission, duplicate publication, guest authorship, honorary authorship, ghost authorship, undisclosed conflicts of interest, or other forms of scientific misconduct.
All submitted manuscripts may be checked with plagiarism detection software. If ethical concerns are identified before publication, the Editorial Office may request explanations, source data, ethics approval documents, consent forms, or other relevant documentation from the authors.
If misconduct or serious error is suspected after publication, the Editorial Office will investigate the case in accordance with COPE guidance. Depending on the outcome, the journal may publish a correction, issue an expression of concern, retract the article, or take another appropriate editorial action.
Authors are expected to cooperate with the Editorial Office during any investigation. When necessary, the Editorial Office may contact the authors’ institution, funder, or relevant ethics committee.
Corrections, Retractions and Expressions of Concern
Journal of Stomatology is committed to maintaining the integrity of the scientific record. When necessary, the journal may publish corrections, expressions of concern, or retractions.
A correction may be issued when an article contains an error that does not invalidate the main findings.
An expression of concern may be issued when serious doubts arise but the investigation is not yet complete.
A retraction may be issued when the findings are unreliable due to misconduct, major error, unethical research, plagiarism, duplicate publication, or other serious breaches of publication ethics.
Post-publication Corrections/Erratum
Post-publication corrections, including errata, may be published when an error is identified after publication but the main conclusions of the article remain reliable. Corrections should be linked to the original article and should clearly identify the corrected article, the nature of the error, and the corrected information.
Authors are required to inform the Editorial Office promptly if they discover a significant error or inaccuracy in their published work.
Retractions
Retraction notices will remain publicly available and will be linked to the retracted article. The notice should state who is retracting the article and explain the reason for retraction, while avoiding defamatory language.
Retracted articles will not be removed from the journal record unless exceptional legal or safety reasons require removal. The article record should be clearly marked as retracted.
Style and Language
Manuscripts must be written in clear, concise, and grammatically correct scientific English. Either American or British English may be used, but the selected style must be consistent throughout the manuscript.
Authors are responsible for the linguistic quality of the manuscript before submission. Manuscripts requiring substantial language editing may be returned without external review.
Redundant, overly descriptive, promotional, or informal language should be avoided. Standard medical and dental terminology should be used consistently throughout the manuscript.
Typography and Formatting
Hyphens, en dashes, and em dashes should be used correctly and consistently. Hyphens should be used for compound words, and en dashes should be used for ranges and relationships, for example 5-10 and dose-response. Em dashes should be avoided where possible.
Numerals should generally be used for numbers, except when a number begins a sentence. Formatting should be consistent throughout the manuscript.
Units and Numerical Data
All measurements must be reported using the International System of Units (SI). A space should be used between the numerical value and the unit, for example 5 mg and 10 mm, except for percentages and degrees, for example 10% and 37°C.
Decimal points, not commas, should be used in numerical data. Ranges should be expressed consistently. Laboratory values should be reported with reference ranges where appropriate.
Abbreviations
Abbreviations should be kept to a minimum. All abbreviations must be defined at first mention in the main text and used consistently throughout the manuscript. Abbreviations should be avoided in the title and minimized in the abstract.
Additional Submission Requirements
Manuscripts must be prepared in a way that does not disclose author identity during double-blind peer review. The main text file, figures, tables, and supplementary files should be anonymized where possible.
Recommended manuscript length, excluding abstract, references, tables, figure legends, and supplementary material, is: original research articles up to 4000 words; clinical research articles up to 4000 words; review articles up to 5000 words; short communications up to 2500 words; letters/correspondence up to 1000 words; and exceptional case series up to 3000 words.
The Editors reserve the right to request shortening of manuscripts that exceed the recommended length or contain material that is not essential for the scientific message.
Files should be submitted separately and clearly named, for example Main text, Title page, Figure 1, Table 1, Supplementary file 1.
Ethical Requirements and Publication Standards
Authors must comply with the journal Ethical Standards and Procedures. Studies involving human participants, human data, human biological material, identifiable images, or medical records must comply with the Declaration of Helsinki and must include ethics committee approval or a clear explanation of exemption or waiver.
Written informed consent must be obtained where required. Patient anonymity must be strictly preserved, and identifying information must not be disclosed unless essential for scientific purposes and written consent for publication has been obtained.
Studies involving animals must comply with applicable institutional, national, and international guidelines for the care and use of animals and must include appropriate ethics approval or justification where applicable.
Authors are encouraged to follow international reporting guidelines, including CONSORT, STROBE, PRISMA, ARRIVE, CARE, and other EQUATOR Network guidelines where applicable.
All authors must confirm that the manuscript is original, has not been published previously, and is not under consideration elsewhere. All submissions may be screened for plagiarism and text overlap.
Copyright and Licensing
Authors should ensure that they have permission to use any copyrighted material, including figures, tables, photographs, and previously published content, where required. Appropriate attribution must be provided for all reused or adapted material.
The journal website should clearly state the copyright and licensing terms applicable to published articles. If articles are published in open access, the applicable Creative Commons licence and author copyright policy should be stated on the journal website and in the article metadata.
Final Remarks
The Editors reserve the right to make necessary stylistic, grammatical, and formatting corrections that do not alter the scientific meaning of the manuscript.
All required documents and declarations must be submitted with the manuscript. Authors are encouraged to consult the submission checklist before submitting their manuscript.
For questions regarding manuscript preparation or submission, authors should contact the Editorial Office.
Reports from Congresses, Conferences, Symposia, and Courses
Reports from congresses, conferences, symposia, courses, and activities of scientific societies may be considered at the discretion of the Editor. Such reports should be concise, factual, and relevant to the scope of the journal.
Reports should not contain promotional or advertising content, including promotional references to companies, products, services, or brands. Reports may be subject to editorial assessment and may not require external peer review unless they include scientific data or claims that require independent evaluation.
Proofs
Proof corrections should be limited to typographical and production errors. Substantive changes at the proof stage may require editorial approval.
Proofs should be returned within 48 hours. If the Editorial Office does not receive a response within the specified time, the article may proceed to publication after editorial review.
Coverage in
Indexed in
Integrated with
Editorial Policies
